Skip 
Navigation Link

1215 South Walnut Ave.
Demopolis, AL 36732 map map 

Access to Care: 1-800-239-2901

Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Even Small Reductions in Air Pollution Help The HeartHigh Costs Lead Millions of Americans to Shop Abroad for Rx DrugsPandemic Hits Primary Care Practices Hard Across the U.S.: StudyOne-Time Treatment Eases Parkinson's -- in MiceAHA News: Here's What Doctors Know About Immunizations Right Now – You Still Need ThemDoctors' Choice of Anesthesia Could Help Curb Climate ChangeTough State Gun Laws Help Save Lives: StudyBlood Donors Will Get Results of Coronavirus Antibody Test, Red Cross SaysCOVID Got You Scared of Performing CPR? Study Finds Infection Risk Is LowFor Stressed-Out Black Americans, Mental Health Care Often Hard to Come ByHealthDay In-Depth
The AI Revolution: For Patients, Promise and Challenges Ahead">HealthDay In-Depth
The AI Revolution: For Patients, Promise and Challenges Ahead
Women Still Left Out of Much Medical ResearchHealthDay In-Depth
The AI Revolution: Robots Already Helping Humans Deliver Better Care">HealthDay In-Depth
The AI Revolution: Robots Already Helping Humans Deliver Better Care
HealthDay In-Depth
The AI Revolution: Giving Docs a Diagnostic Assist">HealthDay In-Depth
The AI Revolution: Giving Docs a Diagnostic Assist
AHA News: Calorie Data on Menus Could Generate Significant Health, Economic BenefitsPandemic Has Left Nearly 43 Million Americans Without WorkPeople Are Avoiding the ER During COVID-19 Crisis at Their Peril: StudyAs Postponed Surgeries Resume, Can U.S. Hospitals Handle the Strain?Most Americans Still More Worried About COVID-19 Spread Than the EconomyBig Need for Blood Donations as Postponed Surgeries ResumeEmergency Transport Can Surprise Many With Big BillsOnly Half of Americans Say They'd Get a Coronavirus Vaccine: SurveyIf Prescribed Opioids for Pain, Ask Lots of Questions: FDAState Texting Bans Are Saving Teen Drivers' LivesMillions of Older Americans Can't Get Enough FoodLayoffs and Losses: COVID-19 Leaves U.S. Hospitals in Financial CrisisFDA Goes After Unproven COVID-19 Antibody TestsDuring Droughts, Many Poor Americans Will Lack Clean Tap Water: StudyDid the Movie 'Joker' Reinforce Prejudice Against Mentally Ill?AHA News: How to Get the Most Out of Health AppsCoronavirus Conspiracy Theories Abound, and They Could Cause Real HarmAHA News: Health Emergency? Don't Hesitate to Get HelpAn Expert's Guide to Fact-Checking Coronavirus Info OnlineRacial, Ethnic Gaps in Insurance Put Moms, Babies at Risk: StudyCelebrity Suicides Spawn 'Copycat' Tragedies, Study Shows
The Doctor Gap: In Areas of Greatest Need, Primary Care Is a Team Effort">
The Doctor Gap: In Areas of Greatest Need, Primary Care Is a Team Effort
The Doctor Gap: Where Are All the Mental Health Care Providers?New, Graphic Health Warnings Coming for U.S. Cigarette PacksWith New Boost From Medicare, 'Telemedicine' Steps Up to Fight CoronavirusThe Doctor Gap: In Rural America, It's All Hands on DeckThe Doctor Gap: A Training Program for Country-Doc WannabesDon't Believe All the 'Science' on CBD ProductsMany Car Crash Deaths Involve Alcohol Levels Below Legal Limit: StudyThe Doctor Gap: Does America Have a Physician Shortage?12 Weeks of Paid Maternity Leave Benefits Everyone: StudyVaping Videos Soaring on YouTubeU.S. Blood Donors Needed in Face of COVID-19 CrisisIt's Tough for Clinical Trial Participants to Learn ResultsBogus Coronavirus 'Meds' Targeted by FDAOnly 1 in 5 Have Fast Access to State-of-the-Art Stroke Care
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

Medicare Could Save Billions If Allowed to Negotiate Insulin Prices

HealthDay News
by By Serena Gordon
HealthDay Reporter
Updated: Feb 4th 2020

new article illustration

TUESDAY, Feb. 4, 2020 (HealthDay News) -- If you don't need insulin, you probably haven't paid much attention to its skyrocketing cost, but new research shows that exorbitant drug pricing eventually affects everyone.

The study found that in 2017, Medicare spent nearly $8 billion on insulin. The researchers said that if Medicare were allowed to negotiate drug prices like the U.S. Department of Veterans Affairs (VA) can, Medicare could save about $4.4 billion just on insulin.

"Medicare now accounts for a third of all drug spending. Legislation allowing Medicare to negotiate prices and establish a central formulary would help save taxpayers money," said the study's lead author, Dr. William Feldman.

"We just looked at insulin, but other studies have shown other drugs would have savings as well," Feldman added. He's a research fellow at Brigham and Women's Hospital and Harvard Medical School in Boston.

The VA already has the ability to get discounts on drugs and to negotiate prices. It has also established a national formulary. A formulary is a list of drugs that are approved for treating certain conditions. Feldman said if a formulary only accepts a few drugs for each condition, there's more competition and flexibility in pricing as companies try to get their drug included.

Other governments -- like Canada -- use their large buying power to negotiate better prices. But the law that established Medicare Part D said Medicare cannot interfere with negotiations between health plans and pharmaceutical companies, according to the journal Health Affairs. That means Medicare Part D, by law, cannot negotiate drug prices like other governments do.

And that lack of negotiation has had a big impact on pricing.

Lija Greenseid, a Minneapolis mother of a teenager with type 1 diabetes, saw those differences first-hand when her family traveled overseas. A box of insulin pens has cost the family as much as $700 in the United States. That same box was $73 in Germany, $57 in Israel, $51 in Greece and $61 in Italy. (Those prices were based on 2017 exchange rates.)

"It's completely outrageous what we pay here," Greenseid said.

To see what effect the ability to negotiate prices and set up a formulary might have on insulin prices in the United States, researchers looked at Medicare Part D spending in 2017. They compared insulin prices between Medicare Part D and what the VA paid for the same medications.

In all, they looked at 31 different insulins.

Total spending on insulin for Medicare Part D was $7.8 billion after manufacturer rebates. If Medicare had been able to use the same prices negotiated by the VA, it would have saved $2.9 billion.

If Medicare could use VA pricing and a national formulary, the projected savings would be $4.4 billion, the study found.

"We were looking at a drug that's been around for 100 years and should be cheaper. Medicare now accounts for a third of all drug spending. If Medicare negotiated prices, it could make a huge difference in health care spending," Feldman said.

The findings were published online Feb. 3 as a letter in JAMA Internal Medicine.

Dr. Robert Steinbrook, an editor-at-large of the journal, wrote an accompanying editorial.

"The evidence indicates that formulary restrictions and price negotiations can decrease the cost of drugs," he said. "There are opportunities for the federal government to save billions of dollars each year for Medicare beneficiaries."

Steinbrook said it's important for people to realize that there are effective measures that can slash drug costs.

"Now is the time for Congress and the executive branch to act," he said.

More information

If you're having trouble affording insulin, the American Diabetes Association has a website detailing where to get insulin help.